Loading clinical trials...
Loading clinical trials...
Over 1.25 million Americans have type 1 diabetes (T1D), increasing risk for early death from cardiorenal disease. The strongest risk factor for cardiovascular disease (CVD) and mortality in T1D is dia...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
NCT01209000 · Minimal Change Disease (MCD), Membranous Nephropathy, and more
NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more
NCT05668403 · Primary Membranous Nephropathy
NCT07157787 · Primary Membranous Nephropathy
NCT07222137 · Diabetes Mellitus, Type 1
Children's Hospital Colorado
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions